Back to top
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Image: Bigstock
Kala Pharmaceuticals (KALA) Crossed Above the 50-Day Moving Average: What That Means for Investors
Kala Pharmaceuticals (KALA - Free Report) reached a significant support level, and could be a good pick for investors from a technical perspective. Recently, KALA broke through the 50-day moving average, which suggests a short-term bullish trend.
The 50-day simple moving average is a widely used technical indicator that helps determine support or resistance levels for different types of securities. It's one of three major moving averages, but takes precedent because it's the first sign of an up or down trend.
KALA could be on the verge of another rally after moving 31.9% higher over the last four weeks. Plus, the company is currently a Zacks Rank #2 (Buy) stock.
Looking at KALA's earnings estimate revisions, investors will be even more convinced of the bullish uptrend. There have been 2 higher compared to none lower for the current fiscal year, and the consensus estimate has moved up as well.
Investors may want to watch KALA for more gains in the near future given the company's key technical level and positive earnings estimate revisions.